The World Health Organization just removed hydroxychloroquine from the world-wide collaborative Solidarity Trial.
The trial which Canada is involved in aims to find an effective COVID-19 treatment.
According to a statement sent by the WHO, the trial’s Executive Group and principal investigators made the decision based on evidence from the Solidarity Trial, UK’s Recovery trial, and a Cochrane review of other evidence on hydroxychloroquine.
The data from all three sources concludes that hydroxychloroquine does not result in the reduction of mortality of hospitalized COVID-19 patients when compared with standard of care.
The release notes that this decision applies only to the Solidarity trial and does not apply to the drug’s possible use as a preventative measure.